# SCGB1D2

## Overview
SCGB1D2 is a gene that encodes the protein Secretoglobin family 1D member 2, also known as lipophilin B, which is part of the secretoglobin family. This protein is primarily expressed in secretory tissues, including the skin and sweat glands, where it is secreted as part of sweat. SCGB1D2 is characterized by its alpha-helical structure, forming an antiparallel dimer capable of binding small to medium-sized ligands, such as steroids and phospholipids. This structural feature is significant for its proposed role in antimicrobial defense, particularly against Borrelia burgdorferi, the bacterium responsible for Lyme disease (Strausz2022Secretoglobin; Strausz2024SCGB1D2). The protein's ability to form heterodimers with SCGB2A proteins and further associate into tetramers suggests a complex role in cellular processes and immune modulation (Jackson2011Update). Variants in the SCGB1D2 gene, such as the missense variant rs2232950, have been linked to altered protein function and increased susceptibility to Lyme disease, highlighting its clinical significance (Strausz2024SCGB1D2).

## Structure
The SCGB1D2 protein, also known as Secretoglobin family 1D member 2, is characterized by its alpha-helical structure, forming an antiparallel dimer of two monomers. This dimeric structure includes a cavity that can accommodate small to medium-sized ligands, such as steroids and phospholipids, which is significant for its function in inhibiting bacterial growth (Strausz2022Secretoglobin; Strausz2024SCGB1D2). The protein's secondary structure is stabilized by an H3-helix backbone, with the Pro53 residue initiating this structure. A common missense variant, rs2232950, results in a substitution from proline to leucine (Pro53Leu), which is predicted to destabilize the alpha-helical structure and affect the dimerization affinity of SCGB1D2 (Strausz2024SCGB1D2).

SCGB1D2 is expressed in secretory tissues, particularly in the skin and sweat glands, and is secreted as part of sweat, suggesting its role in antimicrobial defense (Strausz2024SCGB1D2). The protein's quaternary structure involves forming heterodimers with SCGB2A proteins, which can further associate to form tetramers (Jackson2011Update). The protein is also known to form a covalent complex in an antiparallel manner with mammaglobin A (SCGB2A2) in certain tissues (Zafrakas2006Expression).

## Function
SCGB1D2, a member of the secretoglobin protein family, is primarily expressed in the skin, particularly in sweat gland cells, and is secreted as part of sweat. This protein is believed to have antimicrobial properties, similar to other peptides found in sweat, such as dermcidin and lysozyme, suggesting a role in the body's defense mechanism against pathogens (Strausz2022Secretoglobin; Strausz2024SCGB1D2). SCGB1D2 inhibits the growth of Borrelia burgdorferi, the bacterium responsible for Lyme disease, indicating its potential role in protecting against infections (Strausz2022Secretoglobin; Strausz2024SCGB1D2).

The protein's expression is highest in both sun-exposed and non-sun-exposed skin, and it is also present in other secretory tissues like the salivary gland and mammary tissue (Strausz2024SCGB1D2). SCGB1D2 forms heterodimers with SCGB2A proteins, which further associate to form tetramers, indicating a structural role in cellular processes (Jackson2011Update). Although the specific function of SCGB1D2 in healthy human cells is not fully understood, its widespread expression in various tissues implies a role in normal cellular processes, potentially related to its co-expression with mammaglobin A (Zafrakas2006Expression).

## Clinical Significance
Mutations in the SCGB1D2 gene, particularly the missense variant rs2232950, which results in a proline to leucine substitution at position 53 (P53L), have been associated with increased susceptibility to Lyme disease. This variant is predicted to be deleterious, reducing the protein's ability to inhibit the growth of Borrelia burgdorferi, the bacterium responsible for Lyme disease (Strausz2022Secretoglobin; Strausz2024SCGB1D2). The P53L variant is linked to a destabilization of the protein's ɑ-helical structure, potentially affecting its dimerization affinity, which is crucial for its antibacterial function (Strausz2024SCGB1D2).

The SCGB1D2 protein is primarily expressed in skin and sweat gland cells, suggesting its role as a host defense factor against Borrelia burgdorferi. Alterations in SCGB1D2 expression or mutations affecting its function could influence susceptibility to Lyme disease by impacting the bacterium's ability to grow and establish infection (Strausz2024SCGB1D2). The study of SCGB1D2 also highlights the role of HLA alleles, such as HLA-DQB1*06:02, in modulating immune responses to Lyme disease, indicating a complex interaction between genetic factors and disease susceptibility (Strausz2022Secretoglobin).

## Interactions
SCGB1D2, also known as lipophilin B, is part of the secretoglobin family and is known to form heterodimers with SCGB2A proteins, such as SCGB2A2. These heterodimers can further associate to form tetramers, indicating a potential role in complex protein interactions (Jackson2011Update). The specific functions of these complexes are not fully understood, but they are believed to be involved in various biological processes, including immune modulation and possibly in the regulation of chemotactic migration and invasion, as seen with other members of the SCGB1D subfamily (Jackson2011Update).

In the context of cancer, SCGB1D2 has been identified as being upregulated upon the knockdown of the HOXB7 gene in breast cancer cells, suggesting a regulatory interaction where HOXB7 may repress SCGB1D2 expression (Heinonen2015Identification). This interaction highlights the potential involvement of SCGB1D2 in cancer-related pathways, although the precise mechanisms remain to be elucidated. The protein's interactions, particularly its ability to form complexes with other secretoglobins, suggest a role in modulating cellular responses, although specific interactions with nucleic acids have not been detailed in the available literature.


## References


[1. (Heinonen2015Identification) Henna Heinonen, Tatiana Lepikhova, Biswajyoti Sahu, Henna Pehkonen, Päivi Pihlajamaa, Riku Louhimo, Ping Gao, Gong‐Hong Wei, Sampsa Hautaniemi, Olli A. Jänne, and Outi Monni. Identification of several potential chromatin binding sites of <scp>hoxb7</scp> and its downstream target genes in breast cancer. International Journal of Cancer, 137(10):2374–2383, June 2015. URL: http://dx.doi.org/10.1002/ijc.29616, doi:10.1002/ijc.29616. This article has 27 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ijc.29616)

[2. (Zafrakas2006Expression) Menelaos Zafrakas, Beate Petschke, Andreas Donner, Florian Fritzsche, Glen Kristiansen, Ruth Knüchel, and Edgar Dahl. Expression analysis of mammaglobin a (scgb2a2) and lipophilin b (scgb1d2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies. BMC Cancer, April 2006. URL: http://dx.doi.org/10.1186/1471-2407-6-88, doi:10.1186/1471-2407-6-88. This article has 63 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2407-6-88)

3. (Strausz2022Secretoglobin) Secretoglobin family 1D member 2 (SCGB1D2) protein inhibits growth of Borrelia burgdorferi and affects susceptibility to Lyme disease. This article has 2 citations.

[4. (Jackson2011Update) Brian C Jackson, David C Thompson, Mathew W Wright, Monica McAndrews, Alfred Bernard, Daniel W Nebert, and Vasilis Vasiliou. Update of the human secretoglobin (scgb) gene superfamily and an example of “evolutionary bloom” of androgen-binding protein genes within the mouse scgb gene superfamily. Human Genomics, 5(6):691, 2011. URL: http://dx.doi.org/10.1186/1479-7364-5-6-691, doi:10.1186/1479-7364-5-6-691. This article has 72 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1479-7364-5-6-691)

[5. (Strausz2024SCGB1D2) Satu Strausz, Erik Abner, Grace Blacker, Sarah Galloway, Paige Hansen, Qingying Feng, Brandon T. Lee, Samuel E. Jones, Hele Haapaniemi, Sten Raak, George Ronald Nahass, Erin Sanders, Pilleriin Soodla, Urmo Võsa, Tõnu Esko, Nasa Sinnott-Armstrong, Irving L. Weissman, Mark Daly, Tuomas Aivelo, Michal Caspi Tal, and Hanna M. Ollila. Scgb1d2 inhibits growth of borrelia burgdorferi and affects susceptibility to lyme disease. Nature Communications, March 2024. URL: http://dx.doi.org/10.1038/s41467-024-45983-9, doi:10.1038/s41467-024-45983-9. This article has 3 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-45983-9)